Neuraxpharm

Sustainability Report and Carbon Intensity Rankings

Is Neuraxpharm doing their part?

Their DitchCarbon score is 60

Neuraxpharm has a DitchCarbon Score of 60 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s efforts to manage its carbon intensity, suggesting that while they are making progress, there is still room for improvement. A higher score would denote stronger performance in reducing carbon intensity and enhancing overall sustainability.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Neuraxpharm is part of the research and development sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Neuraxpharm is situated in Spain, which has a low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by reducing its carbon footprint.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Neuraxpharm

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

8.64%

...this company is doing 8.64% better in emissions than the industry average.

Neuraxpharm is a prominent entity in the research and development sector, specializing in pharmaceutical products for the Central Nervous System. Founded in Sant Joan Despí, the company has established itself as a European leader since its inception. It offers a wide range of services, including the development, production, and marketing of CNS therapeutic solutions.

Compare Neuraxpharm with other companies in the same industry –>

emission intelligence's platform recommendations for Neuraxpharm

Neuraxpharm could reduce its emissions by transitioning to renewable energy sources for all purchased electricity, heat, steam, and cooling, potentially achieving a 30% reduction in its Scope 2 emissions.

Good news, Neuraxpharm has embraced SBTi climate commitments

Neuraxpharm has pledged to set science-based targets through the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions in line with climate science. This commitment means the company will develop a detailed plan to significantly cut its carbon footprint across its operations and value chain.

Participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

Neuraxpharm

Sustainability Report and Carbon Intensity Rankings

Is Neuraxpharm doing their part?

Their DitchCarbon score is 60

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Medium

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Neuraxpharm

...this company is doing 8.64% better in emissions than the industry average.

emission intelligence's platform recommendations for Neuraxpharm

Good news, Neuraxpharm has embraced SBTi climate commitments

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch